…en though the study tanked, they did manage to help one person. But this time was different. Clinical oncologist David Solit, director of developmental therapeutics at Sloan-Kettering, saw a new opportunity to explain what happened by sequencing the whole genome of the woman’s c...
Results for “Solit”
Search across the indexed text of every released document.
Names that match “Solit”
4 documents found
…“exceptional responders”: those rare cancer patients who do well while nobody else does. Cancer is a personal disease, Solit explains. Each tumor constitutes its own world of defective genes and proteins. By studying the genetic quirks of exception- al responders, physicians can...
” Solit says. “She had the mutation that
Solit’s group solved another exceptional